Gene: SYNGAP1
Official Full Name: synaptic Ras GTPase activating protein 1provided by HGNC
Gene Summary: This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08977 | SYNGAP1 Knockout cell line (HeLa) | Human | SYNGAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO08978 | SYNGAP1 Knockout cell line (HCT 116) | Human | SYNGAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO08979 | SYNGAP1 Knockout cell line (HEK293) | Human | SYNGAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO08980 | SYNGAP1 Knockout cell line (A549) | Human | SYNGAP1 | 1:3~1:4 | Negative | Online Inquiry |
SYNGAP1 Gene Knockout Cell Lines are specialized biological tools designed to facilitate the study of SYNGAP1, a gene integral to synaptic function and cognitive processes. These cell lines have been genetically modified to inactivate the SYNGAP1 gene, allowing researchers to investigate its role in neuronal signaling pathways and its implications in neurodevelopmental disorders, notably those associated with intellectual disabilities and autism spectrum disorders.
The primary mechanism of these knockout cell lines lies in the targeted gene editing, which effectively disrupts the expression of SYNGAP1. This interruption aids in elucidating the gene's function by providing a model that mimics the pathophysiological conditions observed in certain genetic disorders. Through various assays, researchers can observe changes in synaptic plasticity, excitatory/inhibitory balance, and communication between neurons, all pivotal for understanding the molecular basis of cognitive functions.
The scientific importance of SYNGAP1 Gene Knockout Cell Lines extends to both basic research and clinical applications. In a research setting, these models serve as critical platforms for studying gene function and drug discovery, thereby accelerating the development of potential therapeutic interventions. Clinically, they can help elucidate the genetic underpinnings of SYNGAP1-related disorders, providing essential insights that may lead to targeted treatments.
Compared to alternative models, such as traditional wild-type cell lines or other genetic knockout models, SYNGAP1 knockouts offer specificity and relevance in studying synaptic signaling mechanisms directly tied to human cognitive functions. These cell lines are not only easier to manipulate but also allow for high-throughput screening and reproducible results, making them a cornerstone for researchers aiming to explore the intricate biology of synapses.
For researchers and clinicians focusing on neurodevelopmental disorders, the SYNGAP1 Gene Knockout Cell Lines represent a valuable resource that promises to bridge conceptual gaps in our understanding of synaptic health and disease. Our company prides itself on a robust background in genetic editing technologies and a commitment to providing cutting-edge biological products that empower the scientific community to unlock new discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.